Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data - Quiz - MDSpire

Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data

  • By

  • Mohammed Salah Salem

  • Yola Moride

  • Bernard Bégaud

  • July 13, 2026

Share

Original Source(s)

Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data

  • by Mohammed Salah Salem, Yola Moride, Bernard Bégaud

  • July 13, 2026

Related Content

ACP Ranks Obesity Drug Options

A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.

Embedding structural and social determinants of cardiovascular health into medical education: a systematic review of pedagogical frameworks

Nontraditional lipid and lipid-inflammatory parameters for risk stratification of abnormal glucose metabolism: a cross-sectional study in Chinese adults